Bioluminescence enhanced enzyme immunoassay for human alpha-atrial natriuretic peptide using luciferin-luciferase.
A sensitive bioluminescent enzyme immunoassay (BEIA) for the determination of human alpha-atrial natriuretic peptide was developed. The usable ranges of the standard curve extend from 10 pg to 400 pg for the one-step method and from 2.5 to 50 pg for the two-step method.
Fraysse
M
M
Laboratoire de Physiologie, UFR de Pharmacie, Limoges, France.
Galen
F X
FX
Habrioux
G
G
D000469:Alkaline Phosphatase / Q000378:metabolism; D009320:Atrial Natriuretic Factor / Q000032:analysis*; D049454:Firefly Luciferin / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D007700:Kinetics; D008156:Luciferases / Q000378:metabolism; D008163:Luminescent Measurements
D049454:Firefly Luciferin; D009320:Atrial Natriuretic Factor; D008156:Luciferases; D000469:Alkaline Phosphatase